Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Prostascint

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
INTRODUCTION In this study, a structurally modified phosphoramidate scaffold, with improved prostate-specific membrane antigen… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2014
Highly Cited
2014
PURPOSE We prospectively evaluated the amino acid analogue positron emission tomography radiotracer anti-3-[(18)F]FACBC compared… Expand
Is this relevant?
Review
2013
Review
2013
PURPOSE Molecular imaging methods may identify primary prostate cancer foci and potentially guide biopsy and optimal management… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • table 3
Is this relevant?
Review
2010
Review
2010
  • Ronnie C. Mease
  • Current topics in medicinal chemistry
  • 2010
  • Corpus ID: 22232950
Prostate cancer (PCa) is the second leading cause of cancer deaths in American men. Early detection of PCa by blood tests for… Expand
Is this relevant?
2008
2008
PURPOSE We evaluate the usefulness of pretreatment (111)Indium capromab pendetide (ProstaScint) planar imaging… Expand
Is this relevant?
Review
2005
Review
2005
PURPOSE OF REVIEW Despite marked stage migration, approximately a third of patients with clinically organ-confined prostate… Expand
Is this relevant?
Review
2001
Review
2001
PURPOSE Capromab pendetide (ProstaScint) is an indium In 111 ((111)In)-labeled monoclonal antibody to prostate-specific membrane… Expand
Is this relevant?
2001
2001
I agreed to enter a debate siding against the value of indium-111 (In)-capromab pendetide (Cyt-356) (ProstaScint) imaging with… Expand
Is this relevant?
2000
2000
We report on the demonstration of nonspecific accumulation of indium-111 capromab pendetide (ProstaScint) in neurofibromas in a… Expand
Is this relevant?